Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. - Wikidata - wikimedia - TriplyDB

Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.

Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.

http://www.wikidata.org/entity/Q31131792

about

Endometriosis, angiogenesis and tissue factor IKK2 inhibition attenuates laser-induced choroidal neovascularization Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin.A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration Inhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II.Complement factor h is critical in the maintenance of retinal perfusion.Animals as models of age-related macular degeneration: an imperfect measure of the truth.Animal models of choroidal and retinal neovascularization.Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization.Role of ocular complement factor H in a murine model of choroidal neovascularization.Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration Inhibitory role of adiponectin peptide I on rat choroidal neovascularization.Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.Evidence for enhanced tissue factor expression in age-related macular degeneration.Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment.Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization.Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.Immunological factors in the pathogenesis and treatment of age-related macular degeneration.Tissue factor with age-related macular degeneration.Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer.Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy.Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.Tissue factor pathway inhibitor: structure-function.Association of polymorphisms in complement component 3 with age-related macular degeneration in an Iranian population.A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs.The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization.Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON.Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets.Protection of tight junction between RPE cells with tissue factor targeting peptide

P2860

Q27013803-816E83BC-B4EC-4428-A2A0-11B5141F464C Q28539266-5D564AAF-0921-4343-BC76-ADC51EFEF89A Q33279027-09131E9A-AF63-40F9-A5D1-53C2AE86E54D Q33283093-C2EB50DD-F963-452D-BD4B-D1B6359295F6 Q33415294-396C03AB-5828-4FE8-BA42-3FA0AD50839C Q33440992-6E686A15-7F6A-4A17-9AD4-F910BAB25116 Q33471110-7A8654EC-1E4D-436A-973A-61AF255DED92 Q33552165-110284D0-12E2-4212-8EE3-A9DDDE526A30 Q33582933-AC53DBC2-CF73-44E7-BF38-7080BE4F5CE8 Q33588136-0EDD4F37-6CD8-4F35-ACD0-90A6E23C9C30 Q33597282-BE9B7939-5CB2-4C80-950C-13F5C04A4C9B Q33647292-6A652EF5-446B-46AC-A643-4008DCC1D4C6 Q33683222-7AB6FE90-9FE3-4F5B-817B-D71F389FBE1D Q33715830-D0517216-25C5-43BA-9954-8474BD60B28B Q33880596-43CD0BD4-FD42-4E22-93B6-F7F121A17E83 Q34076104-4B549019-BBF3-49DB-BB1E-1384CFD7495E Q34283258-CC8EA610-D1E7-448C-857C-22FF9BF0A79A Q34451693-42C51A7F-AF06-45DF-A354-6629F6765065 Q34744314-6612AFF1-6A96-4DC9-883A-59B3A96C16DA Q34762840-FF2C779D-D5BE-496E-9223-DF5E32E52D3E Q34909956-7F461EEF-D583-45F7-816D-5DBBFA36C795 Q35006931-168FA3A8-5E40-4CBD-BCD0-35C87AC1A48D Q35191438-BE8A60A7-DC55-447D-895E-6F5854B5DBF7 Q36086191-5A297921-0A6C-44FF-B175-F482B863DB3A Q36358685-68FEFD80-1C95-474E-A4D1-12A6BECB52B6 Q37633792-8B34CE15-E4EF-4D45-B523-3C5E6C3FD011 Q37639757-6E31990F-2F71-45B4-BFE4-FB23FF0E55FB Q37702117-CF05AAD5-98A1-407F-8519-C828B6B5F932 Q37971520-6085EB88-8C64-42DC-8125-D9E357C5BDA8 Q39876637-6DD2E87D-4AF5-45A8-82B3-AECD10760152 Q41113194-D7B5E37D-E3C1-4A3D-9BF2-5C96731FF3C9 Q41764457-93D7CB25-02BA-4D0A-9924-621B820825A8 Q47689628-79E1480A-0481-461E-B22C-D634073EC2A8 Q52721270-7B4832AE-3D61-4887-9ABC-82DB9F41528B Q54962618-571D1307-23B6-45A3-8A95-7C6EAAF6A965 Q58597167-9D41865F-43C5-452D-9FA9-A274FDCCF178

P2860

Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.

http://www.wikidata.org/entity/Q31131792

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.

@ast

Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.

@en

type

label

Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.

@ast

Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.

@en

prefLabel

Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.

@ast

Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.

@en

P1433

Q31131792-40174F1B-22B9-4978-9ECC-A157D6DBEAAD

P1476

Q31131792-7DAAE021-D602-4C70-B06A-492C562147C9

P2093

Q31131792-72E9B9F9-8007-4B5E-89E0-2370E45AAD27

Q31131792-750361D6-F44D-4DE3-A19D-00BA06FFA5B6

Q31131792-80A3D037-86BE-400E-8C18-D4C4B2C91AC5

Q31131792-9A187B99-2D27-4735-B830-4792E4A142EE

Q31131792-DF610036-114E-421A-8C58-74D2FB9CB8DB

Q31131792-E80D84D1-DB2C-4AD8-9958-98C28607B538

Q31131792-FF859B87-B2AD-49C6-AA94-1E3D7A92FF04

P2860

Q31131792-0A8948E1-4A70-413B-BA95-8C736DA6CFCF

Q31131792-150C662A-3998-4A91-8767-C13DEB7F880F

Q31131792-1BE2EF12-853B-49A1-813D-C6E756F92818

Q31131792-26EC30E2-8AA0-49BB-A75E-4D6431FC6764

Q31131792-3030E615-56D4-4D94-992F-F3CEEDD1C678

Q31131792-6182B8D8-03A6-4DA3-B91C-15CF7CB9C666

Q31131792-71BAE7B1-CB07-436B-975B-D2F90F6EE712

Q31131792-74D9526B-72C3-4E42-8109-957F1A4C2E3F

Q31131792-76A20FBB-EA63-46D4-9F80-726AF37B575C

Q31131792-7F89CECA-B6E7-44E9-A579-BF2A43280AB8

P304

Q31131792-74704823-4B88-48CF-B730-F36A4ACDA489

P31

Q31131792-BE434E02-BCDF-4342-A7FD-802695B214DA

P356

Q31131792-A4827505-5727-482A-986F-50365C4BA0E0

P407

Q31131792-FFEBD418-9F5C-49BA-BF55-C094092437CA

P433

Q31131792-C43C4F5B-4C5B-4932-A686-92854A66A91D

P478

Q31131792-DB3D5DE7-376E-45B9-A536-FC752137C866

P50

Q31131792-682E0E34-6AA9-4804-94E9-4CDBAD8A04DB

Q31131792-CFE70744-D294-4294-ADFB-BF54D959A84A

P577

Q31131792-303E5E0A-A13A-4A60-934C-7F8D01231CDD

P5875

Q31131792-6CB75B8E-D13A-4387-BC7A-2791BA3FBC2A

P698

Q31131792-75BA4552-4983-4F39-8E18-FD3C7EED6727

P921

Q31131792-205C88AE-7B83-4D7B-A758-7F0A6B102C7A

Q31131792-33CC19F7-EEB2-4794-A08A-DBD151BE7DB5

P932

Q31131792-363A07AD-C72E-491B-83DC-78262756B837

P356

PNAS.0438014100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.

@en

P2093

Alan Garen

http://www.w3.org/2001/XMLSchema#string

Henry J Kaplan

http://www.w3.org/2001/XMLSchema#string

Jeong-Hyeon Sohn

http://www.w3.org/2001/XMLSchema#string

Jose M C Cruz

http://www.w3.org/2001/XMLSchema#string

Nalini S Bora

http://www.w3.org/2001/XMLSchema#string

Shin Goo Kang

http://www.w3.org/2001/XMLSchema#string

Tongalp H Tezel

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

A simplified system for generating recombinant adenoviruses

Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

Age-related macular degeneration.

Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report.

Human single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement.

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results.

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

P304

2679-2684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0438014100

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10898369

http://www.w3.org/2001/XMLSchema#string

P698

12589025

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

151400

http://www.w3.org/2001/XMLSchema#string